Pay in 4 interest-free payments of $14.75 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression
1618672-71-1
ISRIB blocks multiple stress effectors
MI-2 was used at 10-25 µM concentration in vitro and in the cellular assays
CB-5083 - p97 AAA ATPase Inhibitor. CAS# 1542705-92-9 0187 The novel Aurora A kinaseCB 5083, CAS No. 1542705 92 9, is a novel first in class, potent orally bio available p97 inhibitor that disrupts cellular protein homeostasis and demonstrates anti tumor activity in solid and hematological models . CB 5083 causes rapid and sustained accumulation of poly ubiquitin in tumor xenografts after a single administration. CB 5083 showed activity to inhibit tumor growth in multiple rodent models of human cancer. Furthermore, CB 5083 appears to
US$ 56.00
US$ 18.00
US$ 52.00
US$ 44.00